125 related articles for article (PubMed ID: 92490)
1. An in vitro procedure for the estimation of thyroid hormone releasing factors in sera of thyrotoxic patients.
Maayan ML; Volpert EM; Dawry FP
J Endocrinol Invest; 1978 Oct; 1(4):299-304. PubMed ID: 92490
[TBL] [Abstract][Full Text] [Related]
2. Absence of thyroid-stimulating antibody and long acting thyroid stimulator in relatives of Graves' disease patients.
Banovac K; Zakarija M; McKenzie JM; Witte A; Sekso M
J Clin Endocrinol Metab; 1981 Sep; 53(3):651-3. PubMed ID: 6790561
[TBL] [Abstract][Full Text] [Related]
3. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].
Lamberg BA; Gordin A
Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398
[No Abstract] [Full Text] [Related]
4. Effects of long-acting thyroid stimulator (LATS) and LATS protector on human thyroid adenyl cyclase activity.
Kendall-Taylor P
Br Med J; 1973 Jul; 3(5871):72-5. PubMed ID: 4740444
[TBL] [Abstract][Full Text] [Related]
5. Thyroid hormone secretion is more sensitive than thyroid cyclic AMP accumulation to stimulation with LATS in mice in vitro and in vivo.
Ikeda H; Chiu SC; Kuzuya N; Uchimura H; Nagataki S
J Endocrinol Invest; 1984 Feb; 7(1):1-6. PubMed ID: 6325527
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of LATS and TSH in the blood.
Lemarchand-Béraud T; Griessen M; Scazziga BR
Ann Clin Res; 1972 Jun; 4(3):121-37. PubMed ID: 4625026
[No Abstract] [Full Text] [Related]
7. Stimulation of thyroidal iodothyronine 5'-monodeiodinase by long-acting thyroid stimulator (LATS).
Wu SY; Reggio R; Florsheim W; Chopra IJ; Solomon DH
Acta Endocrinol (Copenh); 1987 Feb; 114(2):193-200. PubMed ID: 3825441
[TBL] [Abstract][Full Text] [Related]
8. New in vitro tests to detect the thyroid stimulator in sera from hyperthyroid patients by measuring colloid droplet formation and cyclic AMP in human thyroid slices.
Onaya T; Kotani M; Yamada T; Ochi Y
J Clin Endocrinol Metab; 1973 May; 36(5):859-66. PubMed ID: 4349046
[No Abstract] [Full Text] [Related]
9. Norepinephrine and thyrotropin effects on the thyroid in vitro: simultaneous stimulation of iodide organification and antagonism of thyroxine release.
Maayan ML; Volpert EM; From A
Endocrinology; 1981 Sep; 109(3):930-4. PubMed ID: 6167436
[TBL] [Abstract][Full Text] [Related]
10. [Studies on the radioreceptor assay of TSH: the binding of 125I-TSH to the human thyroid receptor and the interaction of LATS-IgG (author's transl)].
Endo K
Nihon Naibunpi Gakkai Zasshi; 1979 Oct; 55(10):1249-60. PubMed ID: 228997
[TBL] [Abstract][Full Text] [Related]
11. Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease.
Orgiazzi J; Williams DE; Chopra IJ; Solomon DH
J Clin Endocrinol Metab; 1976 Feb; 42(2):341-54. PubMed ID: 946604
[TBL] [Abstract][Full Text] [Related]
12. Involvement of alpha 1-adrenergic receptors in the inhibitory effect of catecholamines on the thyrotropin-induced release of thyroxine by the mouse thyroid.
Muraki T; Uzumaki H; Nakadate T; Kato R
Endocrinology; 1982 Jan; 110(1):51-4. PubMed ID: 6274625
[TBL] [Abstract][Full Text] [Related]
13. Effects of long-acting thyroid stimulator on thyrotropin stimulation of adenyl cyclase activity in thyroid plasma membranes.
Yamashita K; Field JB
J Clin Invest; 1972 Mar; 51(3):463-72. PubMed ID: 4110896
[TBL] [Abstract][Full Text] [Related]
14. The long-acting thyroid stimulatory: is it of importance in Graves' disease.
McKenzie JM; Zakarija M; D'Amour P; Joasoo A
N Z Med J; 1975 Jan; 81(531):18-21. PubMed ID: 165442
[No Abstract] [Full Text] [Related]
15. Does LATS cause hyperthyroidism in Graves' disease? (A review biased toward the affirmative).
McKenzie JM
Metabolism; 1972 Sep; 21(9):883-94. PubMed ID: 4115791
[No Abstract] [Full Text] [Related]
16. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators.
Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ
Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871
[TBL] [Abstract][Full Text] [Related]
17. Evidence that both long-acting thyroid stimulator and long-acting thyroid stimulator-protector stimulate the human thyroid gland.
Holmes SD; Dirmikis SM; Martin TJ; Munro DS
J Endocrinol; 1979 Feb; 80(2):215-21. PubMed ID: 220366
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of thyrotropin- and dibutyryl cyclic AMP-induced secretion of thyroxine and triiodothyronine by catecholamines.
Maayan ML; Debons AF; Krimsky I; Volpert EM; From A; Dawry F; Siclari E
Endocrinology; 1977 Jul; 101(1):284-91. PubMed ID: 193681
[TBL] [Abstract][Full Text] [Related]
19. [TSH and the "long-acting thyroid stimulator" (LATS) in patients with compensated hyperthyroidism].
zur Mühlen A von ; Hesch RD; von Lilienfeld H; Emrich D
Acta Endocrinol Suppl (Copenh); 1971; 152():86. PubMed ID: 5313711
[No Abstract] [Full Text] [Related]
20. Dissociation of serum LATS activity and hyperfunction and autonomy of the thyroid gland in Graves' disease.
Hennemann G; Dolman A; Docter R; De Reus A; Van Zijl J
J Clin Endocrinol Metab; 1975 Jun; 40(6):935-41. PubMed ID: 1173367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
